Nick Tate

Vice President, Head of NEXT

Haleon

Anya Sizer

Fertility in the Workplace Director

Fertility Network

Sarah Churchman

OBE, Chief Inclusion, Community & Wellbeing Officer

PWC

Carolyn Harris

MP, Chair of All

Party Parliamentary Group on Menopause

Pippa Andrews

Director, Corporate Business

Vitality

Kate Lancaster

CEO

Royal College of Obstetricians and Gynaecologists

Mazen Ahmad

Senior Data Scientist

Janssen

Philippe Moingeon

Associate Principal Informatician

Moingeon

Philippe MOINGEON received his PhD in immunology from Paris XI University, and an MBA from Open University Business School (Newcastle, UK). He was formerly Resident of Paris Hospitals (1981-1986), Post-doctoral fellow (1987-1990) and Assistant Professor (1991-1994) at the Dana Farber Cancer Institute, Department of Pathology, Harvard Medical School (Boston, USA).

 

Philippe has extensive experience in the development of biologicals, holding several positions in the vaccine industry, including Head of the Cancer Vaccine program and General Secretary for Research and Development, at Aventis Pasteur (1994-2003), as well as Senior Vice President, Research and Pharmaceutical Development at Stallergenes (2003-2017). He joined Servier in September 2017, to head the Center for Therapeutic Innovation for immuno-inflammatory diseases.

 

Two vaccines registered in Europe, USA and Japan, 230 scientific publications in peer-reviewed journals, 23 patents/ patent applications.

 

Current scientific interests: artificial intelligence and computational modelling in support of drug development; applications to auto-immune, inflammatory and neurological diseases.